Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 49.90
-0.30 (-0.60%)
At close: Feb 11, 2026
TPEX:4160 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 589.13 | 661.86 | 592.5 | 547.81 | 519.51 | 443.13 | |
Revenue Growth (YoY) | -11.33% | 11.71% | 8.16% | 5.45% | 17.24% | 3.20% |
Cost of Revenue | 348.97 | 381.84 | 355.67 | 321.37 | 324.02 | 301.84 |
Gross Profit | 240.16 | 280.01 | 236.83 | 226.44 | 195.49 | 141.29 |
Selling, General & Admin | 170.24 | 166.88 | 164.46 | 153.25 | 149 | 130.54 |
Research & Development | 64.55 | 63.6 | 54.47 | 52.32 | 51 | 32.09 |
Operating Expenses | 235.23 | 230.48 | 218.25 | 206.28 | 200.02 | 162.86 |
Operating Income | 4.93 | 49.53 | 18.58 | 20.15 | -4.53 | -21.58 |
Interest Expense | -0.43 | -0.52 | -0.42 | -0.11 | -0.04 | -0 |
Interest & Investment Income | 2.31 | 5.21 | 5.12 | 2.77 | 1.65 | 2.24 |
Currency Exchange Gain (Loss) | -0.98 | 2.77 | 0.29 | 3.49 | -1.95 | -0.88 |
Other Non Operating Income (Expenses) | 10.47 | 9.53 | 10.05 | 9.42 | 14.92 | 3.96 |
EBT Excluding Unusual Items | 16.31 | 66.51 | 33.62 | 35.72 | 10.06 | -16.26 |
Gain (Loss) on Sale of Investments | 1.21 | 0.49 | 1.12 | -2.53 | 0.14 | -2.02 |
Gain (Loss) on Sale of Assets | 0.39 | 0.38 | - | - | - | - |
Pretax Income | 17.28 | 67.39 | 34.74 | 33.19 | 10.2 | -18.28 |
Income Tax Expense | 3.85 | 12.53 | 5.97 | 7.24 | 2.19 | -2.87 |
Earnings From Continuing Operations | 13.43 | 54.86 | 28.77 | 25.95 | 8.01 | -15.41 |
Minority Interest in Earnings | -0.07 | -0.16 | -0.2 | -0.22 | -0.17 | -0.3 |
Net Income | 13.36 | 54.7 | 28.57 | 25.73 | 7.84 | -15.71 |
Net Income to Common | 13.36 | 54.7 | 28.57 | 25.73 | 7.84 | -15.71 |
Net Income Growth | -77.16% | 91.49% | 11.01% | 228.24% | - | - |
Shares Outstanding (Basic) | 27 | 27 | 27 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 27 | 27 |
Shares Change (YoY) | -0.10% | -0.01% | -0.10% | 0.41% | 0.19% | -0.35% |
EPS (Basic) | 0.50 | 2.05 | 1.07 | 0.96 | 0.29 | -0.59 |
EPS (Diluted) | 0.49 | 2.04 | 1.06 | 0.96 | 0.29 | -0.59 |
EPS Growth | -77.44% | 92.45% | 10.26% | 230.72% | - | - |
Free Cash Flow | -11.19 | 55.73 | 63.13 | 44.76 | -0.63 | 17.82 |
Free Cash Flow Per Share | -0.42 | 2.08 | 2.35 | 1.67 | -0.02 | 0.67 |
Dividend Per Share | 1.847 | 1.847 | 0.485 | 0.436 | 0.264 | - |
Dividend Growth | 280.58% | 280.58% | 11.30% | 65.50% | - | - |
Gross Margin | 40.77% | 42.31% | 39.97% | 41.34% | 37.63% | 31.88% |
Operating Margin | 0.84% | 7.48% | 3.14% | 3.68% | -0.87% | -4.87% |
Profit Margin | 2.27% | 8.26% | 4.82% | 4.70% | 1.51% | -3.54% |
Free Cash Flow Margin | -1.90% | 8.42% | 10.65% | 8.17% | -0.12% | 4.02% |
EBITDA | 16.59 | 57.22 | 24.81 | 26.7 | 1.79 | -16.36 |
EBITDA Margin | 2.81% | 8.64% | 4.19% | 4.87% | 0.34% | -3.69% |
D&A For EBITDA | 11.66 | 7.69 | 6.23 | 6.55 | 6.32 | 5.22 |
EBIT | 4.93 | 49.53 | 18.58 | 20.15 | -4.53 | -21.58 |
EBIT Margin | 0.84% | 7.48% | 3.14% | 3.68% | -0.87% | -4.87% |
Effective Tax Rate | 22.29% | 18.59% | 17.20% | 21.82% | 21.47% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.